We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.8B Turnover 33.11%
1-Year Est. Return 26.98%
 

Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.

This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+26.98%
3 Year Est. Return
+88.41%
5 Year Est. Return
+62.11%
10 Year Est. Return
+188.73%
AUM
$7.55B
AUM Growth
+$1.25B
Cap. Flow
+$1.17B
Cap. Flow %
15.56%
Top 10 Hldgs %
9.43%
Holding
2,269
New
635
Increased
628
Reduced
448
Closed
556
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17%
2 Financials 13.53%
3 Healthcare 13.33%
4 Technology 13.18%
5 Industrials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SOS icon
1651
SOS
SOS
$4.22M
$90K ﹤0.01%
6
+4
+200% +$109K
2018 Q1
1 quarter
VSTM icon
1652
Verastem
VSTM
$935M
$85K ﹤0.01%
+1,029
New +$63K
2018 Q2
0 quarters
CVRS
1653
DELISTED
Corindus Vascular Robotics
CVRS
$84K ﹤0.01%
+102,300
New +$98.7K
2018 Q2
0 quarters
INTT icon
1654
inTEST
INTT
$161M
$83K ﹤0.01%
11,400
-8,400
-42% -$59.7K
2017 Q4
2 quarters
MUX icon
1655
McEwen
MUX
$668M
$83K ﹤0.01%
+4,015
New +$85.8K
2018 Q2
0 quarters
TTPH
1656
DELISTED
Tetraphase Pharmaceuticals
TTPH
$83K ﹤0.01%
+1,164
New +$82.2K
2018 Q2
0 quarters
MLNT
1657
DELISTED
Melinta Therapeutics
MLNT
$82K ﹤0.01%
2,568
-852
-25% -$30.7K
2018 Q1
1 quarter
HOV icon
1658
Hovnanian Enterprises
HOV
$540M
$81K ﹤0.01%
1,979
+1,072
+118% +$50.6K
2017 Q4
2 quarters
KODK icon
1659
Kodak
KODK
$800M
$81K ﹤0.01%
21,257
-41,839
-66% -$212K
2018 Q1
1 quarter
MBIO icon
1660
Mustang Bio
MBIO
$2.96M
$81K ﹤0.01%
+16
New +$101K
2018 Q2
0 quarters
PCTI
1661
DELISTED
PCTEL
PCTI
$79K ﹤0.01%
12,600
-700
-5% -$4.81K
2017 Q3
3 quarters
AGFS
1662
DELISTED
AgroFresh Solutions Inc
AGFS
$79K ﹤0.01%
11,234
-266
-2% -$1.92K
2018 Q1
1 quarter
LKM
1663
DELISTED
Link Motion
LKM
$79K ﹤0.01%
+69,687
New +$101K
2018 Q2
0 quarters
SOHO
1664
DELISTED
Sotherly Hotels
SOHO
$77K ﹤0.01%
11,100
– –
2017 Q4
2 quarters
HLIT icon
1665
Harmonic Inc
HLIT
$1.1B
$76K ﹤0.01%
+17,934
New +$70.4K
2018 Q2
0 quarters
AMRS
1666
DELISTED
Amyris
AMRS
$75K ﹤0.01%
+11,728
New +$70.4K
2018 Q2
0 quarters
MXWL
1667
DELISTED
Maxwell Technologies
MXWL
$75K ﹤0.01%
+14,411
New +$78.2K
2018 Q2
0 quarters
IBRX icon
1668
ImmunityBio
IBRX
$6.66B
$74K ﹤0.01%
+24,275
New +$89.9K
2018 Q2
0 quarters
XONE icon
1669
DELISTED
ExOne
XONE
$74K ﹤0.01%
+10,476
New +$73.6K
2018 Q2
0 quarters
VIVE
1670
DELISTED
Viveve Med
VIVE
$73K ﹤0.01%
+27
New +$77.8K
2018 Q2
0 quarters
CLDX icon
1671
Celldex Therapeutics
CLDX
$2.2B
$72K ﹤0.01%
+9,583
New +$128K
2018 Q2
0 quarters
SGYP
1672
DELISTED
Synergy Pharmaceuticals
SGYP
$71K ﹤0.01%
+41,051
New +$71K
2018 Q2
0 quarters
IVAC icon
1673
DELISTED
Intevac
IVAC
$69K ﹤0.01%
+14,194
New +$75.3K
2018 Q2
0 quarters
FTD
1674
DELISTED
FTD Companies
FTD
$68K ﹤0.01%
+14,619
New +$81.8K
2018 Q2
0 quarters
PIR
1675
DELISTED
Pier 1 Imports
PIR
$66K ﹤0.01%
+1,380
New +$74.6K
2018 Q2
0 quarters

Similar funds

Squarepoint's Q2 2018 Portfolio in Review

As of Q2 2018, Squarepoint held 2,269 positions worth $7.55B, up 20% from $6.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Squarepoint deployed $1.17B of net new capital in Q2 2018, opening 635 new positions and adding to 628 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI India ETF, an estimated $47.3M trimmed.

  • Squarepoint's largest Q2 2018 buy was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.
  • Squarepoint added most to iShares MSCI Taiwan ETF in Q2 2018, an estimated $102M increase.
  • Squarepoint's biggest Q2 2018 reduction was iShares MSCI India ETF, cutting an estimated $47.3M.
  • Squarepoint fully exited iShares MSCI Brazil ETF in Q2 2018, selling an estimated $119M.
  • Squarepoint's ten largest holdings make up 9.4% of its $7.55B portfolio in Q2 2018.
  • Squarepoint opened 635 new positions and closed 556 in Q2 2018.
  • Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.55B.

Based on Squarepoint's 13F filing for Q2 2018, filed 14 Aug 2018.